Replies to post #23017 on Revive Therapeutics Ltd (RVVTF)

[Bruinfan4ever]

Not a big deal if Bucillamine shows better results. If it's not, well if you can't swish it into the trash can, the bank is still open.

[ragstorum]

Sharing that frustration, Snoop_dog. Revive will be entering a Covid-19 treatment arena as more emerging treatments pop up in the coming months, for different stages of disease.

Challenge will be differentiation and making sure big pharma doesn’t eat our lunch. I see Merck as a true rival here (MK-7110, molnupiravir), hopefully one we can match or beat. I think bucillamine will work well enough for Revive to be competitive.

https://www.bloomberg.com/news/articles/2020-12-23/merck-u-s-deal-for-covid-drug-shows-need-for-therapies-persists

[powerbattles]

I hear your voice loud and clear above the noise. I don't care how they want to slice it still doesn't change the fact Buc is a better drug than Colchicine.